https://www.selleckchem.com/pr....oducts/troglitazone-
021). A multivariate analysis revealed that performing prophylactic urethrectomy was the only independent predictor of the overall survival rate (P=0.016). In those patients who were treated without neoadjuvant chemotherapy (n=38), the 5-year overall survival rate was significantly higher in the prophylactic urethrectomy group than in the non-prophylactic urethrectomy group (P=0.007). Prophylactic urethrectomy at the time of radical cystectomy may have a survival benefit in patients with multiple tumours and/or concomitant c